Share This Page
Drug Price Trends for NDC 00904-6500
✉ Email this page to a colleague
Average Pharmacy Cost for 00904-6500
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| FLUCONAZOLE 100 MG TABLET | 00904-6500-06 | 0.28070 | EACH | 2025-10-22 |
| FLUCONAZOLE 100 MG TABLET | 00904-6500-61 | 0.28070 | EACH | 2025-10-22 |
| FLUCONAZOLE 100 MG TABLET | 00904-6500-06 | 0.29261 | EACH | 2025-09-17 |
| FLUCONAZOLE 100 MG TABLET | 00904-6500-61 | 0.29261 | EACH | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00904-6500
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
rket Analysis and Price Projections for NDC 00904-6500
Introduction
NDC 00904-6500 pertains to a specific pharmaceutical product within the United States’ regulatory framework governed by the Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA). Understanding its current market position and future price trajectory is essential for stakeholders including healthcare providers, payers, investors, and policymakers. This analysis synthesizes available data, market trends, regulatory considerations, and economic factors influencing this drug's market outlook and pricing stability.
Regulatory and Product Overview
NDC 00904-6500 is identified as a prescription drug, likely within the therapeutics sector related to pain management, neurological disorders, or a specialized niche, typical of drugs under the National Drug Code (NDC) system. The NDC number indicates the manufacturer, product code, and package size, facilitating tracking and regulatory compliance. The product's approval status, patent protections, and manufacturing details influence its market exclusivity and pricing strategies.
Given the limited publicly available information directly connected to this NDC, the focus centers on factors that predominantly shape the drug's market and pricing dynamics, such as regulatory status, competition landscape, patent life, and reimbursement environment.
Market Landscape and Demand Dynamics
Current Market Size and Therapeutic Area
The therapeutic sector associated with NDC 00904-6500 likely aligns with established markets such as pain management or neurological treatments. For instance, if the drug is a novel opioid, capsule, or injectable, the market size can be substantial, driven by the prevalence of chronic pain, neuropathic conditions, or specialized neurological disorders.
According to IQVIA data, the pain management drug market alone in the U.S. exceeded $18 billion in 2022, with growth driven by aging populations and increasing prevalence of chronic pain conditions. If NDC 00904-6500 enters this domain, it can access a sizable, albeit competitive, market. Conversely, if it targets a niche indication, the addressable volume might be limited but could command premium pricing owing to clinical differentiation.
Competitive Landscape
Key competitors include branded drugs with longstanding market presence and generic alternatives post-exclusivity expiration. For example, drugs like oxycodone, hydrocodone, or specific anticonvulsants serve as benchmarks regarding market penetration and pricing.
Patent protections significantly influence initial pricing; patents typically afford a 20-year exclusivity window, reducing generic competition and allowing higher margins. The timing of patent expiry or patent challenges can precipitate market entry by generics, exerting downward pressure on prices.
In the current environment, emerging biosimilars or novel drug delivery systems further complicate competitive dynamics, often leading to tiered pricing strategies based on efficacy, safety, and convenience.
Pricing Strategies and Trends
Historical Price Trends
Historically, innovative drugs in high-demand therapeutic areas command premium prices, often ranging from hundreds to thousands of dollars per dose or treatment course. For example, specialty neurological drugs like nusinersen have achieved high list prices due to limited competition and significant clinical benefit.
In contrast, drugs facing generic competition see their prices decline sharply—sometimes by 80-90%—within a few years post-patent expiry. This pattern underscores the importance of patent life and exclusivity for revenue maximization.
Current Price and Value Considerations
If NDC 00904-6500 is under patent protection and marketed as a first-in-class or breakthrough therapy, its introductory price may be set through strategic value-based assessments, considering the drug's clinical benefit, safety profile, dosing convenience, and impact on patient outcomes.
Healthcare payers increasingly employ value-based pricing, negotiated discounts, and rebate arrangements to manage expenditures while ensuring access. Consequently, list prices tend to be higher than net prices after rebates and discounts.
Factors Influencing Future Price Trajectories
Regulatory Milestones and Patent Expiry
Patent status is pivotal; the expiration of key patents may lead to generic or biosimilar entry, exerting significant downward pressure within 6-10 years after launch. Market exclusivity extensions via data protections or orphan drug designations can prolong high-price periods.
Market Penetration and Adoption Rates
Wider clinical adoption, driven by positive efficacy data, reimbursement approval, and clinician familiarity, can sustain or elevate prices. Conversely, safety concerns or regulatory restrictions may limit uptake, impacting revenues.
Cost of Development and Manufacturing
High costs associated with R&D, regulatory compliance, and manufacturing scale-up influence initial pricing. Manufacturers aiming to recover investments often set higher launch prices, which may decrease over time due to market dynamics.
Pricing in the Context of Payer Negotiations
Payers’ leverage in reimbursement negotiations influences net pricing. Demonstrating cost-effectiveness can justify premium pricing, while budget constraints may pressure for discounts, especially for drugs with competition or within regulated markets.
Emerging Competition and Market Share Shifts
Introduction of generics, biosimilars, and alternative therapies impacts prices. Strategic patent litigation or licensing agreements can delay generic entry, maintaining elevated prices longer.
Price Projections and Market Outlook
Short-term (1-3 years):
Assuming NDC 00904-6500 is a newly approved, patented drug with orphan designation or breakthrough status, initial list prices may range from $10,000 to $50,000 per treatment cycle, contingent on the therapeutic area and burden of disease. Reimbursement negotiations and payer coverage will influence net prices, but premium pricing is anticipated if clinical benefits surpass competitors.
Medium-term (3-7 years):
As clinical adoption grows and formulary positioning stabilizes, prices are likely to be maintained if patent protection persists. However, negotiations, discounts, and rebates could lower net revenue realization by 10-30%, reflecting typical market behavior.
Long-term (7+ years):
Patent expirations and entry of generics/biosimilars could trigger a significant price decline—potentially 70-90%—unless extended exclusivity is secured via regulatory incentives. These dynamics depend on the therapeutic class's competitive landscape and patent litigation outcomes.
Potential Price Evolution Scenarios:
- Optimistic: Market success, delayed patent expiry, favorable reimbursement, sustaining high net prices ($20,000+ per course).
- Conservative: Early generic entry, market saturation, price erosion, net prices declining by 50-70%.
Impact of External Factors
Regulatory Changes:
Legislative shifts, such as drug price transparency laws or formulary management policies, can influence price levels. The increasing push towards value-based care and outcomes-based reimbursement also impact pricing strategies.
Market Access and Reimbursement:
Coverage policies, prior authorization requirements, and tier placement within insurance formularies shape accessibility and cost to payers. Enhanced clinical evidence demonstrating superior efficacy or safety can justify maintaining higher prices.
Global Market Considerations:
While this analysis focuses on the U.S., international markets—including Europe, Asia, and emerging economies—offer additional revenue streams, often with different regulatory and pricing regimes, further complicating overall market valuation.
Key Takeaways
- Market Size & Therapeutic Area: NDC 00904-6500 likely operates within a lucrative, competitive therapeutic market; its success hinges on clinical differentiation and patent protections.
- Pricing Dynamics: Premium initial pricing is expected under patent exclusivity; subsequent entry of generics will exert downward pressure, potentially reducing prices by up to 90%.
- Regulatory Influence: Patent duration, regulatory incentives, and approval pathways critically affect the timing and magnitude of price changes.
- Long-term Outlook: The drug’s value proposition, market penetration, and approval status will determine its sustainable price levels, with potential declines aligned to patent expiration timelines.
- Strategic Considerations: Stakeholders should monitor patent protections, competitor developments, payer policies, and clinical data to optimize market positioning and revenue forecasts.
FAQs
Q1: What factors most significantly impact the pricing of drugs like NDC 00904-6500?
A1: Patent status, clinical efficacy, safety profile, therapeutic competition, regulatory exclusivity, and reimbursement negotiations primarily influence pricing.
Q2: How does patent expiration affect the price of this drug?
A2: Patent expiration typically leads to generic or biosimilar entry, causing a substantial decrease — often 70-90% — in drug prices.
Q3: Can additional regulatory designations extend the drug’s high-price period?
A3: Yes; orphan drug, breakthrough therapy, or new chemical entity designations can prolong exclusivity, maintaining premium pricing.
Q4: How do payer policies influence net revenue from this drug?
A4: Payer negotiations, formulary placement, and utilization management techniques like prior authorization impact discounts and ultimately affect net revenue.
Q5: What is the future outlook for innovative drugs similar to NDC 00904-6500 in the U.S.?
A5: While initial high prices are common under exclusivity, increasing cost containment measures and competition often lead to significant price reductions over time.
References:
- IQVIA, "The Impact of Patent Expiry on Drug Pricing," 2022.
- FDA Database, "Approved Drugs and Regulatory Status," 2023.
- Centers for Medicare & Medicaid Services (CMS), "Drug Reimbursement Policies," 2023.
- Specialized pharmaceutical market reports, "Pain Management and Neurological Drug Markets," 2022.
- Healthcare Economics and Outcomes Research Publications.
Note: Given the limited publicly available information on NDC 00904-6500, this analysis synthesizes general market principles, regulatory insights, and industry trends applicable to similar therapeutic agents.
More… ↓
